Ashiya, Japan

Mikio Saitoh

This inventor holds 2 USPTO granted patents. Top assignees: Eisai Company, Limited, Mitsubishi Chemical Industries Limited. Active years: 1985-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mikio Saitoh. Retrieved from https://idiyas.com/inventor/mikio-saitoh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1985-1986

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Mikio Saitoh: Innovator in Pharmaceutical Composition

Introduction

Mikio Saitoh is a notable inventor based in Ashiya, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mental symptoms associated with organic disorders in the brain. With a total of 2 patents, Saitoh's work has the potential to impact many lives.

Latest Patents

Saitoh's latest patents focus on the pharmaceutical composition of 2-(4-Methylaminobutoxy)diphenylmethane and its pharmaceutically acceptable salts. These compounds have been found to be useful for the improvement and treatment of mental symptoms caused by organic disorders in the brain. His innovative approach aims to provide effective solutions for individuals suffering from these conditions.

Career Highlights

Throughout his career, Mikio Saitoh has worked with prominent companies such as Mitsubishi Chemical Industries Limited and Eisai Company, Limited. His experience in these organizations has contributed to his expertise in pharmaceutical development and innovation.

Collaborations

Saitoh has collaborated with various professionals in his field, including his coworker Shizuo Kuriyama. Their joint efforts have further advanced the research and development of effective pharmaceutical compositions.

Conclusion

Mikio Saitoh's contributions to the pharmaceutical industry highlight his dedication to improving mental health treatment. His innovative patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…